GSK, Theravance initiate treatment in ‘081 Phase IIb study
‘081 is a single molecule functioning as both a muscarinic antagonist and a beta2 receptor agonist (MABA). ‘081 is an investigational compound within the inhaled bifunctional muscarinic antagonist-beta2
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.